{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T16:40:04Z","timestamp":1683823204193},"reference-count":18,"publisher":"Japanese Society of Hypertension","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1291\/hypres.30.105","type":"journal-article","created":{"date-parts":[[2007,4,27]],"date-time":"2007-04-27T05:10:19Z","timestamp":1177650619000},"page":"105-107","source":"Crossref","is-referenced-by-count":2,"title":["Inflammation and Salt Sensitivity in the Early State of Hypertension"],"prefix":"10.1291","volume":"30","author":[{"given":"Tomohiro","family":"KATSUYA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"RAKUGI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"OGIHARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.185"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Manning RD Jr, Meng S, Tian N: Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. <i>Acta Physiol Scand<\/i> 2003; <b>179<\/b>: 243-250.","DOI":"10.1046\/j.0001-6772.2003.01204.x"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000070028.99408.E8"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1159\/000086411"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr: Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. <i>Hypertension<\/i> 2005; <b>45<\/b>: 934-939.","DOI":"10.1161\/01.HYP.0000160404.08866.5a"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tian N, Rose RA, Jordan S, Dwyer TM, Hughson MD, Manning RD Jr: <i>N<\/i>-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. <i>J Hypertens<\/i> 2006; <b>24<\/b>: 2263-2270.","DOI":"10.1097\/01.hjh.0000249705.42230.73"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000056768.03657.B4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zhou MS, Hernandez Schulman I, Pagano PJ, Jaimes EA, Raij L: Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. <i>Hypertension<\/i> 2006; <b>47<\/b>: 81-86.","DOI":"10.1161\/01.HYP.0000197182.65554.c7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kobori H, Ozawa Y, Suzaki Y, <i>et al<\/i>: Young Scholars Award Lecture: intratubular angiotensinogen in hypertension and kidney diseases. <i>Am J Hypertens<\/i> 2006; <b>19<\/b>: 541-550.","DOI":"10.1016\/j.amjhyper.2005.11.014"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.521"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Szalai C, Duba J, Prohaszka Z, <i>et al<\/i>: Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 <NOBR>&minus;2518<\/NOBR> G\/G genotype in CAD patients. <i>Atherosclerosis<\/i> 2001; <b>158<\/b>: 233-239.","DOI":"10.1016\/S0021-9150(01)00423-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Larrousse M, Bragulat E, Segarra M, Sierra C, Coca A, de La Sierra A: Increased levels of atherosclerosis markers in salt-sensitive hypertension. <i>Am J Hypertens<\/i> 2006; <b>19<\/b>: 87-93.","DOI":"10.1016\/j.amjhyper.2005.06.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM: Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. <i>Circ Res<\/i> 1998; <b>83<\/b>: 952-959.","DOI":"10.1161\/01.RES.83.9.952"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tian N, Gu JW, Braddy SJ, Rose RA, Hughson MD, Manning RD Jr: Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. <i>Am J Physiol Heart Circ Physiol<\/i> 2006 (PMID 17040973).","DOI":"10.1096\/fasebj.20.4.A333-c"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nakagawa T, Kang DH, Ohashi R, <i>et al<\/i>: Tubulointerstitial disease: role of ischemia and microvascular disease. <i>Curr Opin Nephrol Hypertens<\/i> 2003; <b>12<\/b>: 233-241.","DOI":"10.1097\/00041552-200305000-00003"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060838"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Aljada A, Ghanim H, Saadeh R, Dandona P: Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. <i>J Clin Endocrinol Metab<\/i> 2001; <b>86<\/b>: 450-453.","DOI":"10.1210\/jcem.86.1.7278"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1038\/ng1877"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T16:20:29Z","timestamp":1683822029000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.30.105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.30.105","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}